Panerai, Alberto E, Vecchiet, Jacopo, Panzeri, Paolo et al. · The Clinical journal of pain · 2002 · DOI
This study measured a natural pain-relieving substance called beta-endorphin in immune cells from people with ME/CFS, fibromyalgia, depression, and healthy controls. The researchers found that people with ME/CFS and fibromyalgia had significantly lower levels of beta-endorphin than healthy people and those with depression. This suggests the immune systems of people with ME/CFS and fibromyalgia may be working differently than in other conditions.
This study suggests ME/CFS and fibromyalgia may share a distinct immune system dysfunction marked by low beta-endorphin levels, which could eventually help distinguish these conditions from depression and other illnesses. Finding measurable biological differences supports the concept that ME/CFS is a biological condition involving immune dysregulation, not purely psychological.
This study does not prove that low beta-endorphin causes ME/CFS or fibromyalgia—it only shows an association. The small sample sizes mean results need replication in larger populations before any biomarker could be used clinically. It also does not explain what causes the beta-endorphin reduction or whether correcting it would improve symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.